Cryptomonadales normalize blood sugar levels for diabetes patients
I am not sure if this is important to most diabetes patients. It's not that old yet a lot of people do not know this headlines from taiwan....
http://www.etaiwannews.com/Taiwan/2002/11/06/1036544858.htm
Below is the extract of the article:
Cryptomonadales normalize blood
Sugar levels for diabetes patients, says institute
2002-11-06 / Taiwan News, Staff Reporter / By Yvonne Tsai
The National Health Research Institute yesterday confirmed research results, which showed the effect of cryptomonadales in lowering blood
Sugar and blood fat in diabetes patients.
The NHRI reported that after continuously taking doses of cryptomonadales for 30 days, 90 percent of research patients showed a 25 percent decline in blood fat, and the blood
Sugar levels of diabetes sufferers improved to within healthy limits.
NHRI research team director Su Yi-ren stated that cryptomonadales are a species of green algae, which, after long-established evidence of their ability to reduce blood fat and blood sugar, have now been proven to have those benefits. However, the Department of Health has not yet officially recognized green algae as a health food.
According to International Chlorella Co. Ltd., cryptomonadales are a unicellular plant containing chlorophyll, vitamins and high levels of protein. When applied in medication, cryptomonadales have been used to cure or alleviate many kinds of chronic diseases, including cancer, anemia, lupus, sterility and so on. In order to gain scientific proof, International Chlorella Co. Ltd entrusted National Cheng Kung University Hospital to conduct several experiments and to provide pilot research on human subjects.
NHRI Bio-technology and medical research deputy director Chien Chih-sian said that five years ago, more than ten patients suffering from heart disease and diabetes were found to have seen an improvement in their health after taking green algae products. Further research found that the curative effects were due to cryptomonadales.
Through clinical observation, it has been discovered that diabetes is strongly linked to high blood fat diseases, and current medication has serious side effects. It is reported that if the activating factor can be refined in cryptomonadales, it could be used to benefit diabetes patients.
During the tests, 30 test patients took 30 cryptomonadales doses each day over the period of one month. The NHRI said that positive effects were noticeable after two weeks. After one month, 90 percent of the subjects had reduced blood fat levels by 25 percent.
The Bureau of Health Promotion under the Health Department stated that an estimated 360,000 people in Taiwan suffer from diabetes without knowing it. People with diabetes are 17 times more likely to suffer retina deterioration. Therefore, the bureau urged people over 40 to be tested to find out if they have diabetes in order to reduce their chances of blindness.
Center for Disease Control consultant Huang Kao-bin discovered that diabetes patients infected with dengue fever have a higher death rate. Huang indicated that diabetes will cause pathological changes to blood vessels, and dengue hemorrhage fever can cause bleeding and thromboplastin malfunctions, both affecting blood vessels. The reason diabetes patients have a higher susceptibility to theses diseases' symptoms is still unknown.
According to the NHRI, diabetes is the fifth most common cause of death in Taiwan, with around 10,000 people dying of diabetes last year. Statistics from the Business Communications Co. show that the global market for diabetes medication exceeds US$11.7 billion.
At present, treatment for diabetes largely consists of medication and diet control, in combination with exercise. Diet control is considered the most important of these measures.
The NHRI and International Chlorella Co. Ltd. will conduct a three-year research project to make use of scintillation proximity assay to sift cryptomonadales components and look for the activating factor to enhance body insulin reception, increase insulin activation and reduce blood fat.